Anesthesia Preference for Intravitreal Injection: Topical or Subconjunctival

NCT01640171 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

57

Enrollment

OTHER

Sponsor class

Conditions

Age-related Macular Degeneration
Central Retinal Vein Occlusion
Diabetic Macular Edema

Interventions

PROCEDURE: Xylocaine 2% Injectable Anesthetic
DRUG: Proparacaine Hydrochloride 0.5% Drop
DRUG: Tetravisc 0.5% Gel
DRUG: Acuvail
DRUG: Intra-vitreal Anti-VEGF Drug

Sponsor

Retina Vitreous Associates of Florida